NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production (Q46982725)
Jump to navigation
Jump to search
scientific article published on 2 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production |
scientific article published on 2 January 2013 |
Statements
1 reference
NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production (English)
1 reference
Issaka Yougbaré
1 reference
Gilles Boire
1 reference
Michelle Roy
1 reference
Claire Lugnier
1 reference
Eric Rouseau
1 reference
2 January 2013
1 reference
91
1 reference
5
1 reference
353-361
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference